RBMS1 and breast cancer: We found that the glycosyltransferase beta-1,4-galactosyltransferase 1 (B4GALT1) was one of the top hits whose expression level was significantly decreased upon RBMS1 depletion in breast cancer cells (Figs. 4A and S4A–B).